Podcasts about american colleges

Strap in and grab your NG tubes, because the EGS team in TIGER Country is taking you on a fast, forceful, and evidence-packed ride through 15 years of global SBO literature. From the OG 2011 Zielinski model to the latest 2025 predictive tools sweeping across Europe and North America, we're breaking down what matters when the bowel stops behaving and the clock starts ticking.  Join Dr. Rushabh Dev and the Acute Care Surgery crew at the University of Missouri as they tackle the most common EGS consult in America with humor, data, and real-world pearls. Get ready for CT red flags, strangulation scores, Gastrografin truths, and the eternal battle between “operate early” vs. “wait it out.” Whether you're a med student trying to decode your first CT or a seasoned attending debating the next Gastrografin challenge, this episode delivers the insights you need to Dominate the Day. Participants: Dr. Rushabh Dev FACS (Moderator, Surgical Attending) – Assistant Professor of Surgery, Associate PD ACS & SCCM Fellowship, SICU Medical Director, Lieutenant Commander United States Navy Reserve   Dr. Raymond Okeke; Acute Care Surgery & SCCM Fellow  Dr. Eugene Ismailov, General Surgery Resident; PGY 5 Dr. Brycen Ratcliffe, General Surgery Resident; PGY 4 Dr. Desra Flecher, General Surgery Resident; PGY 3 Objectives: 1. Identify the core clinical and CT predictors of operative need in SBO including mesenteric edema, free fluid, closed-loop obstruction, lack of enhancement, and feces sign absence — and understand how these features have remained consistent across 15 years of research. 2. Compare major international SBO predictive models (Zielinski, Geneva Severity Score, STRISK, and NOFA) and describe how they inform real-time decision-making in North American acute care surgery. 3. Apply evidence-based algorithms, including the 2025 JTACS EGS pathway to structure SBO evaluation, integrate Water-Soluble Contrast studies, and avoid delayed surgery in high-risk patients. 4. Evaluate the long-term impact of operative vs. non-operative management with emphasis on recurrence risk, timing between episodes, and how to incorporate recurrence data into patient counseling. 5. Synthesize 15 years of evolving SBO literature into practical bedside strategies by balancing red-flag findings, risk-model guidance, and individualized clinical judgment to optimize outcomes. STRISK and NOFA Calculator: Prediction Models | Clinical Abdominal Surgery Helsinki References  1. Geneva Clinical Severity Score Wassmer, C. H., Guber, J., Zeindler, J., Meier, R. P. H., Ouaïssi, M., Ris, F., Morel, P., Didier, C., & Gkikas, I. (2023). A new clinical severity score for the management of adhesive small bowel obstruction: A cohort study. International Journal of Surgery, 109, 262–270. https://pubmed.ncbi.nlm.nih.gov/37026805/ 2. STRISK & NOFA Predictive Models Räty, S., Rinta-Kilpinen, E., Eklund, M., Turunen, N., Koskinen, I., Rasilainen, S., Korhonen, T., & Paajanen, H. (2025). Development and external validation of prediction risk models for strangulation or non-operative treatment failure in small bowel obstruction: A multicenter prospective study. Surgery, 178(1), 45–56. Prediction Models | Clinical Abdominal Surgery Helsinki 3. JTACS EGS Algorithm – Evidence-Based, Cost-Effective Management Livingston, D. H., Wolfson, D., Cogbill, T. H., Rice, T. W., Patel, N., et al. (2025). Evidence-based, cost-effective management of small bowel obstruction: An Emergency General Surgery Algorithms Work Group project. Journal of Trauma and Acute Care Surgery, 98(4), 512–528. https://pubmed.ncbi.nlm.nih.gov/40842046/ 4. Tennessee Recurrence Study (Operative vs Non-Operative Management) Medvecz, A. J., Dennis, B. M., Wang, L., Countouris, M. E., Croce, M. A., Sharpe, J. P., Ivanova, A., & Miller, R. S. (2020). Impact of operative management on recurrence of adhesive small bowel obstruction: A longitudinal analysis of a statewide database. Journal of the American College of Surgeons, 230(4), 544–551.e1. https://pubmed.ncbi.nlm.nih.gov/31954815/ 5. Early Predictive SBO Work – Zielinski (2010–2011) Zielinski, M. D., Eiken, P. W., Bannon, M. P., Heller, S. F., Lohse, C. M., & Huebner, M. (2010). Small bowel obstruction—Who needs an operation? A multivariate prediction model. World Journal of Surgery, 34(5), 910–919. https://pubmed.ncbi.nlm.nih.gov/20217412/ 6. Zielinski, M. D., Haddad, N. N., Cullinane, D. C., Eiken, P. W., & Huebner, M. (2011). Prospective, observational validation of a multivariate small bowel obstruction model to predict the need for operative intervention. Journal of the American College of Surgeons, 212(6), 1068–1076. https://pubmed.ncbi.nlm.nih.gov/21458305/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKevin Shea, PharmDPharmacist Vytal Options  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-377-H01-PInitial release date: 12/29/2025Expiration date: 12/29/2026Additional CPE details can be found here.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3236: Dr. Neal clears up the confusion around heart rate zones and fat loss, revealing that the often-cited “fat-burning zone” isn't a magic formula. He explains why variety, like combining resistance training with both low and high-intensity cardio, is key to improving fitness, preserving muscle, and boosting fat metabolism over time. Quotes to ponder: "Fat loss is a complicated process. There is no guarantee that working at a certain or target heart rate will lead to fat loss." "Mix up your workout routines. Incorporating variety into your workouts is probably the best thing to do." "Resistance training is the best way to make bigger muscles." Episode references: American College of Sports Medicine: https://www.acsm.org Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Robert McLean, former President of the American College of Physicians discusses the negative impact of the word provider, and encourages all physicians to take the 'No Provider Pledge.'PhysiciansForPatientProtection.org

In this solo podcast, I address the broader argument against aversive tools in dog training promoted by the AVSAB and the R+-only movement.Recently, Dr. Michael Bailey, President of the American Veterinary Medical Association, commented on the use of electronic collars in dog training. That comment triggered backlash and a strong response from Dr. Lisa Radosta, President of the American College of Veterinary Behaviorists.But this presentation is not about personalities.It's about the claim that aversives never have a place in dog training.Using peer-reviewed research, learning theory, and real-world outcomes, I examine whether the “no aversives ever” position is actually supported by evidence and what happens to dogs when ideology overrides results.At the end, I invite you, the trainers and owners, to share stories of dogs who are alive today because balanced training worked when nothing else did.Outcomes matter.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3236: Dr. Neal clears up the confusion around heart rate zones and fat loss, revealing that the often-cited “fat-burning zone” isn't a magic formula. He explains why variety, like combining resistance training with both low and high-intensity cardio, is key to improving fitness, preserving muscle, and boosting fat metabolism over time. Quotes to ponder: "Fat loss is a complicated process. There is no guarantee that working at a certain or target heart rate will lead to fat loss." "Mix up your workout routines. Incorporating variety into your workouts is probably the best thing to do." "Resistance training is the best way to make bigger muscles." Episode references: American College of Sports Medicine: https://www.acsm.org Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode Fred Goldstein invites Sheena Crosby, PharmD, BCGP, Inflammatory Bowel Disease Clinical Pharmacist at the Mayo Clinic in Florida. Sheena breaks down the American College of Gastroenterology's (ACG) updated guidelines for ulcerative colitis and Crohn's disease, highlighting major shifts in treatment strategy, including the move toward earlier use of advanced therapies and updated goals focused on symptom control, mucosal healing, and sustained remission. She also outlines the critical payer considerations emphasized in the guidelines—from eliminating unnecessary step-therapy requirements to ensuring timely access to induction and maintenance therapy—changes that have direct implications for patient outcomes and health-system performance. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

(0:00) Intro(1:31) About the podcast sponsor: The American College of Governance Counsel.(2:18) Start of interview. *Reference to prior episodes with David (E24 from Nov 2020 and E159 from Dec 2024)(3:22) 2025 highlights from the American College of Governance Counsel(4:55) The Rome Conference on AI, Ethics, and the Future of Corporate Governance(6:52) The Dual-Class Share Debate (reference to his paper Performance Leads Governance)(12:06) Emerging Governance Structures in AI companies, including Public Benefit Corporations (PBCs) "mission driven"(23:02) The AI Bubble Debate ("from a technology standpoint, I don't think we're in a bubble. From a valuation standpoint, we may be very well in a bubble.") Reference to my article on AI Washing Goes Criminal.(27:00) Big Tech vs. Little Tech Dynamics "We're going to have, at some point, a shakeout. It's impossible for all of these companies to be successful."(29:55) The Shift to Private Markets(34:15) Delaware's Governance Challenges (*reference to E194 on Silicon Valley 150 Report) "Since TripAdvisor, about 50 companies have left Delaware."(39:45) AI and Cybersecurity in the Boardroom(40:42) On Mandatory Arbitration(42:03) Biggest winner in business in 2025: Tech broadly, Silicon Valley particular.(43:40) Biggest loser in business in 2025: Delaware(45:15) Biggest business surprise in 2025(47:19) Best corporate governance trend from 2025: Renewed and strong focus on ethics.(50:00) Worst corporate governance trend from 2025: Partisanship(50:58) What's the biggest corporate governance trend to watch out for in 2026: the role of politics in the boardroom(51:35) One piece of advice for directors heading into 2026: the role of AI in the boardroom and in the companyDavid Berger is a partner at Wilson Sonsini and the President of the American College of Governance Counsel. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

With the end of 2025 upon us, we wanted to find some of the short stack conversations from the past year. So for this short stack, you'll here our 4 hosts, and frequent guests Matt Delaney and Christ Colbert join us for some random questions that will leave you laughing. Don't forget, we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more about an upcoming CME event!

How Much Vitamin B12 Do We Need Each Day? How are the recommended daily and weekly doses of vitamin B12 derived? And how much fortified food or supplements do we need to take? Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #Plantbasednutrition #b12   ===================== Original post: https://nutritionfacts.org/video/how-much-vitamin-b12-do-we-need-each-day/  ====================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Mariam Alexander, MD, PhD Guest: Jessica S. Donington, MD, MSCR The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn more as Drs. Gerard Silvestri, Mariam Alexander, and Jessica Donington review new data on EGFR- and ROS1-targeted therapies, perioperative immunotherapy, and multidisciplinary strategies to expand resectability in stage III non-small cell lung cancer. Dr. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Alexander is an Assistant Professor of Medical Oncology at the Medical University of South Carolina. Dr. Donington is a Professor in Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Adam H. Fox, MD, MSc Guest: Anurag Singh, MD, PhD From updated surveillance strategies to evolving biopsy techniques and treatment advances, recent findings presented at 2025 conferences are reshaping non-small cell lung cancer management. Dr. Gerard Silvestri speaks with Drs. Adam Fox and Anurag Singh to explore key data influencing diagnostic decisions, patient-centered care, and multidisciplinary treatment planning across stages. Dr. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Fox is a pulmonologist and Assistant Professor of Medicine at the Medical University of South Carolina. Dr. Singh is a Professor of Radiation Oncology and the Director of Radiation Research at the Roswell Park Cancer Center in New York. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

PDFs available here: https://rhesusmedicine.com/pages/cardiologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Timestamps:0:00 What is Heart Failure / Heart Failure Definition0:11 Systolic vs Diastolic Heart Failure 0:31 How is Cardiac Output Calculated2:28 Causes of Heart Failure 4:39 Heart Failure Risk Factors5:24 Signs and Symptoms of Heart Failure6:12 Diagnosis of Heart Failure 7:41 Treatment of Heart Failure (HFrEF vs HFpEF) ReferencesNaing, P., Forrester, D., Kangaharan, N., Muthumala, A.S.M., Myint, S.M. & Playford, D., 2019. Heart failure with preserved ejection fraction. July 2019. [online] Available at: https://www1.racgp.org.au/ajgp/2019/july/heart-failure-with-preserved-ejection-fraction. RACGPLi, P., Zhao, H., Zhang, J., Ning, Y. & Tu, Y., 2021. Similarities and differences between HFmrEF and HFpEF. , 8:678614. [online] Available at: https://www.frontiersin.org/articles/10.3389/fcvm.2021.678614/full. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding, National Center for Biotechnology Information (NCBI), 2020.  Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016826/. NCBIAlbakri, A., 2018. Heart failure with reduced ejection fraction: clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided therapy. Paolucci, L., 2022. New guideline-directed treatments for heart failure. Journal of the American College of Cardiology: Case Reports. Available at: https://www.jacc.org/doi/10.1016/j.jaccases.2021.11.006. jacc.orgNicolas, D., 2024. Sacubitril-Valsartan. In: StatPearls . Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507904/. NCBINational Center for Biotechnology Information (NCBI), 2024. Heart failure: diagnosis, management and prognosis. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961993/.National Center for Biotechnology Information (NCBI), 2024. Heart failure with preserved ejection fraction (HFpEF). Available at: https://www.ncbi.nlm.nih.gov/books/NBK599960/. NCBIDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

igraine disorders affect more than 1 billion people across the globe, yet they remain deeply misunderstood. In this episode, I sit down with Dr. Adam Harcourt to explore the true nature of migraines as a genetic neurological condition and to uncover why so many patients struggle to find lasting relief. Together, we examine the roots of migraine expression, including genetic vulnerability, environmental triggers, hormonal shifts, and the lifestyle factors that amplify neurological stress. Our conversation also dives into the complex relationship between concussion and migraine. These conditions often overlap, or they are mistaken for one another, which can delay the right treatment. Dr. Harcourt explains how functional neurological assessments can help clinicians identify the specific pathways involved and create targeted strategies that match the needs of each patient. We then discuss one of the most promising tools in migraine care: low-level laser therapy. Dr. Harcourt outlines how laser applications can reduce inflammation, support neural recovery, and help patients build resilience against recurring episodes. This episode offers science, clarity, and practical hope for anyone who lives with migraines or treats them in clinical practice.   Key takeaways: Genetic Disposition and Migraine: Migraines are primarily genetically mediated neurological disorders, with significant variations in expression and symptoms, often unrelated to pain. The Bucket Theory: Dr. Harcourt explains how stressors fill up a "bucket," causing migraines when they overflow, highlighting the need for both reducing stressors and expanding the "bucket." Concerns of Misdiagnosis: Many individuals are misdiagnosed with migraine when they may be suffering from post-concussion syndrome, underscoring the importance of precise diagnosis. Therapeutic Innovations: The discussion highlights the potential of low-level laser therapy in treating migraines, offering a non-invasive alternative to Botox and medication. Holistic Approach to Treatment: Emphasizing diet, hormone balance, and neuro-rehabilitation, Dr. Harcourt advocates for an integrated approach to effectively manage and prevent migraines. More About Dr. Adam Harcourt:   Dr. Adam Harcourt is the owner of Harcourt Brain Center currently located in York, PA, with offices formerly in Santa Barbara and Beverly Hills  CA. He is a Fellow of the American College of Functional Neurology (FACFN), Fellow of the American Board of Vestibular Rehabilitation (FABVR), Diplomate of the American Chiropractic Neurology Board (DACNB), and a 4th generation Doctor of Chiropractic. Dr. Harcourt is also an Associate Professor of Clinical Neurology at Carrick Institute for Graduate Studies, where he developed a 150-hour post-doctoral program,  titled 'Mastering Migraine', with which he instructs doctors from all different backgrounds from around the world. Website Instagram Connect with me! Website Instagram Facebook YouTube

In the 200th episode of Health & Veritas, Harlan offers end-of-the-year reflections on medicine drawn from his editor's notes in JACC (the Journal of the American College of Cardiology), and Howie provides updates on gun violence, flu, measles, and the health benefits of yoga. Show notes: Editor's notes by Harlan Krumholz "The Day I Became a Doctor" "When Your Patient Dies" "Rethinking Physician Certification: A Call for a Modern, Meaningful Standard" Gun violence, flu, and measles "Mass shootings outnumber annual days in U.S., children are missing school due to measles, Covid-19 is peeping around the corner, and some hope" "Measles outbreaks worsen in South Carolina, Arizona and Utah" "Connecticut reports first measles case in years" "New Flu Variant May Be Triggering Spike in Severe Disease" "High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults" "Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance" The benefits of yoga "Yoga for chronic non‐specific low back pain" "Yoga-based interventions may reduce anxiety symptoms in anxiety disorders and depression symptoms in depressive disorders: a systematic review with meta-analysis and meta-regression" "Effect of Yoga on Frailty in Older Adults" "Yoga in autoimmune disorders: a systematic review of randomized controlled trials" "Long-term effects of yoga-based practices on neural, cognitive, psychological, and physiological outcomes in adults: a scoping review and evidence map" "Yoga isn't just for flexibility. It may also protect brain health." In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

 Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. In this episode, the docs welcome visiting physician Dr. Shelley Dolitsky from Shady Grove Fertility in Towson, Maryland, for an in-depth conversation about recurrent pregnancy loss. Dr. Dolitsky begins by reviewing how different professional organizations define recurrent pregnancy loss. The American Society for Reproductive Medicine considers two or more losses—including very early biochemical losses—to be recurrent pregnancy loss, while the American College of OB/GYN defines it as two clinical losses under 20 weeks. The docs discuss how age dramatically affects miscarriage risk, with up to 75% of women over 40 experiencing miscarriages, compared with an overall rate of three to five percent. They walk through the full evaluation, which includes assessing the uterine cavity for abnormalities such as scar tissue, polyps, or congenital malformations; ensuring the fallopian tubes are normal and ruling out tubal damage; and performing chromosome analysis on both partners. Testing for antiphospholipid antibodies and lupus anticoagulant is also essential, as these can contribute to placental clotting issues. The conversation highlights the importance of screening for chronic medical issues that might be undiagnosed. About half of patients with recurrent pregnancy loss will have an identifiable and often treatable cause. Finally, the team discusses recommendations for patients whose workup is normal but who continue to experience losses. This podcast was sponsored by Shady Grove Fertility. 

It's YOUR time to #EdUp with Dr. Eric Klein, Assistant Provost, Doctoral Research & Student Success, American College of EducationIn this episode, part of our Academic Integrity Series, sponsored by ⁠Integrity4EducationYOUR cohost is Thomas Fetsch, CEO, Integrity4EducationYOUR host is ⁠Elvin Freytes⁠How does an online university grow enrollment by doubling every year for 5 years while maintaining 85% graduation rates & 95% student satisfaction without raising tuition since 2016?What happens when an institution refuses Title IV funding & offers master's degrees for under $10,000 & doctoral programs under $25,000 while delivering $19.20 in ROI for every $1 students invest?How does a focus on transparency & student centeredness through personalized pathways, immersive VR learning & clear job placement data prepare 12,000 students for lifelong learning in an AI enabled world?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠& ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!P.S. Want to get early, ad-free access & exclusive leadership content to help support the show? Then ⁠⁠​subscribe today​⁠⁠ to lock in YOUR $5.99/m lifetime supporters rate! This offer ends December 31, 2025!

What if the key to self-advocacy wasn't being louder—but rewiring how you think, feel, and connect with empathy?Today, I'm joined by executive coach and podcast host Jamie Lee, who specializes in helping women and underrepresented leaders rise through the ranks without compromising their integrity. We dive into how empathy and neuroplasticity form the foundation of effective self-advocacy — and how rewiring internal narratives can lead to greater confidence, deeper connection, and clarity when speaking up. Jamie shares evidence-based techniques for regulating the nervous system so you can show up with presence and poise in high-stakes conversations. Plus, we touch on the six types of intelligence you can access to build connections and ask for what you want.If you've ever struggled with self-advocacy or want to communicate with more impact and empathy, this episode is for you.To access the episode transcript, go to www.TheEmpathyEdge.com, search by episode title.Listen in for…Defining self-advocacy and neuroplasticity in terms of empathy. Compassion as an action is the key to rewiring your brain. Ways to access your parasympathetic nervous system in your thinking brain and get out of your automatic stress response.Leveraging mirror neurons with empathy and compassion. "The brain adapts. The brain grows. It changes according to the practices that you expose it to. Compassion is the missing link that helps us be able to access those self-advocacy muscles for ourselves." — Jamie Lee Episode References: Book a free hour-long consultation for 1:1 coaching with Jamie: https://www.jamieleecoach.com/applyThe Empathy Edge podcast: Dia Bondi: How to Ask Like an AuctioneerMelissa Tiers' Anti-Anxiety Toolkit: https://www.amazon.com/Anti-Anxiety-Toolkit-Melissa-Tiers-ebook/dp/B0073HU3EGJames Tripp's website: https://www.jamestripp.onlineAbout Jamie Lee, Coach, Trainer, Podcast Host Jamie is an executive coach who specializes in women and underrepresented leaders who are "allergic" to office politics. She focuses on helping them get promoted and better paid without compromising their integrity or throwing anyone under the bus. In her practice, she blends proven self-advocacy strategies with evidence-based neuroplasticity tools.Over a decade, Jamie has trained thousands of professionals in effective self-advocacy at leading organizations, including Citi, Unilever, Association of Corporate Counselors, American College of Cardiologists, UC Berkeley School of Business, and Smith College.She's also the host of the Risky Conversations podcast, where she has honest talks with thought leaders on topics often considered taboo or "too risky" at work -- negotiation, mental and reproductive health, office politics, social injustices, and unconventional ways smart women navigate their path forward despite a flawed workplace. From Our Sponsor:Keynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game-changer for your speaking business! www.share.talkadot.com/mariaross Connect with Jamie:Jamie Lee Coach: jamieleecoach.com LinkedIn: linkedin.com/in/leejieunjamie Instagram: instagram.com/jamieleecoach Connect with Maria:Get Maria's books: Red-Slice.com/booksHire Maria to speak: Red-Slice.com/Speaker-Maria-RossTake the LinkedIn Learning Courses! Leading with Empathy and Balancing Empathy, Accountability, and Results as a Leader LinkedIn: Maria RossInstagram: @redslicemariaFacebook: Red SliceKeynote Speakers and Conference Trainers: Get your free Talkadot trial and enjoy this game changer for your speaking business! www.share.talkadot.com/mariarossGet your copy of The Empathy Dilemma here- www.theempathydilemma.com

The OECD Report for Regional Policy for Greece Post-2020 (https://www.oecd.org/en/publications/regional-policy-for-greece-post-2020_cedf09a5-en.html) revealed that 32% of the population lives in predominantly rural regions which is significantly higher than the OECD average share of rural population which is around 25%. Of those living in predominantly rural regions (~3.4 million people), roughly 3 million live in remote rural regions meaning Greece has one of the largest shares in this demographic among OECD countries. Recorded live from the OECD Rural Development Conference in Rio de Janeiro, Greek officials Vasiliki Pantelopoulou (Secretary-General of the Partnership Agreement) and Christos Kyrkoglou (General Director of Monitoring and Implementation) explain Greece's approach to rural urban development under the European Union's Cohesion Policy and the role of Integrated Territorial Investments (ITIs). They describe their respective roles in coordinating and implementing programmes financed through the Partnership Agreement, stressing the importance of integrating urban and rural policies. Sit back, relax and take a listen! Vasiliki Pantelopoulou is a lawyer and a Member of Athens Bar Association. She graduated from School of Law of the National and Kapodistrian University of Athens and holds two postgraduate degrees (LL.M. in Commercial and Business Law from East Anglia University, U.K., and MSc in Business Administration for Law Practitioners from Alba Graduate Business School, The American College of Greece, Greece). She is a Member of the Board of the Hellenic Development Bank. She has worked for twenty years as an in-house lawyer at STASY – Urban Rail Transport S.A., specialized in the field of public procurement (Law 4412/2016). Since April 2023, she has been the Director of Legal Services at Metavasi S.A. – Hellenic Company for Just Transition S.A. She is a Member of investing Committees such as EQUIFUND I & II, TEPIX III Loan Fund and others. Christos Kyrkoglou is the General Director of Monitoring and Implementation for the ESPA, which operate under the Secretary General. Mr Kyrkoglou holds a Bachelor's Degree in Sociology from Panteion University of Social and Political Sciences, as well as a Master's Degree in Urban and Regional Development from the same institution. In 2023, he was appointed Head of the Special Service for the Coordination of Regional Programs of the General Secretariat for the Partnership Agreement of the Ministry of Economy and Finance. Since 2025, he is Head of the General Directorate for Monitoring and Implementation. His professional interests and fields of expertise span the full spectrum of development interventions under the Partnership Agreement for Regional Development 2021–2027, with a particular focus on employment, human resources development, innovation and entrepreneurship, social policy, territorial development, culture, and the environment. As Public Affairs and Communications Manager, Shayne engages with policy issues concerning SMEs, tourism, culture, regions and cities to name a few. He has worked on a number of OECD campaigns including “Going Digital”, "Climate Action" and "I am the future of work". **** To learn more, visit OECD Latin American Rural Development Conference www.oecd.org/en/events/2025/11/…nt-conference.html and the OECD's work on Rural Development www.oecd.org/en/topics/policy-i…l-development.html. Find out more on these topics by reading Reinforcing Rural Resilience www.oecd.org/en/publications/re…e_7cd485e3-en.html and Rural Innovation Pathways www.oecd.org/en/publications/ru…s_c86de0f4-en.html. To learn more about the OECD, our global reach, and how to join us, go to www.oecd.org/about/ To keep up with latest at the OECD, visit www.oecd.org/ Get the latest OECD content delivered directly to your inbox! Subscribe to our newsletters: www.oecd.org/newsletters

Fecal incontinence (FI) affects nearly 8% of adults worldwide, yet many people suffer in silence due to embarrassment, confusion, or the belief that nothing can be done. This episode is here to change that. We're joined by Dr. John William Blackett, gastroenterologist and lead author of "Fecal Incontinence in Adults: New Therapies," published in The American Journal of Gastroenterology. Dr. Blackett offers a compassionate, patient-centered overview of FI, including common causes, diagnostic testing, and the full range of treatment options available today—highlighting newer and emerging therapies. If you've experienced unexpected leakage, urgency, staining, or difficulty controlling bowel movements—or if you support someone who has—this conversation provides clarity, reassurance, and practical guidance. Effective treatments exist, and help is available. This episode is produced in collaboration with the American College of Gastroenterology Patient Care Committee.

Portability can be a powerful tool—until it isn't. In this new ACTEC Trust and Estate Talk episode, we break down Estate of Rowland v. Commissioner and how an incomplete estate tax return cost the surviving spouse $3.7 million in DSUE. Learn what went wrong, why the relaxed reporting rules didn't apply, and the key steps practitioners should take to safeguard a valid portability election. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Soul Food That's Good for the Soul The best of soul food's origins are tied to the plant-centric West African diet. And that's soul food that's good for the soul! Listen to today's 7-min episode by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #Plantbasednutrition #veganpodcast #plantbasedpodcast #plantbasedbriefing #nutritionfacts #wfpb #soulfood #blackvegan #vegansoulfood ===================== Original post: https://nutritionfacts.org/video/soul-food-thats-good-for-the-soul/  ====================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

In this episode of the Changing Higher Ed® podcast, Dr. Drumm McNaughton speaks with Dr. Ashley Finley, Vice President of Research and Senior Advisor to the President at the Association of American Colleges and Universities (AAC&U), about the findings of the 2025 AAC&U Employer Survey and what they reveal about employer expectations for higher education. Based on nearly 20 years of longitudinal research, the 2025 survey challenges many of the dominant public narratives about the value of college. Employers continue to express strong confidence in higher education, place equal importance on workforce preparation and citizenship, and increasingly emphasize adaptability, judgment, and civic capacity as core professional requirements. Dr. Finley explains how employers view civic skills as workplace competencies, why mindsets and dispositions are now baseline expectations rather than "soft skills," and how AI is reshaping what it means to be prepared for an uncertain future. The conversation also addresses generational differences among employers, the growing role of microcredentials, and why institutions must model the agility they expect from graduates. This episode is especially relevant for presidents, trustees, provosts, and senior leaders navigating political pressure, workforce alignment, and questions about institutional value. Topics Covered: What the 2025 AAC&U Employer Survey reveals that public narratives often miss Why employers see preparing informed citizens and a skilled workforce as inseparable goals How civic skills, including constructive disagreement, translate directly to workplace success Why motivation, resilience, initiative, and self-awareness are now baseline hiring expectations How employers think about AI readiness beyond simple tool proficiency Which student experiences increase hiring likelihood beyond internships How employers evaluate the credibility and value of microcredentials and certificates Generational shifts in employer expectations and what they signal for the future Three Takeaways for University Presidents and Boards: Institutions must communicate learning outcomes more clearly, including mindsets and dispositions, so students can articulate who they are becoming, not just what they know. Career-relevant experiences extend far beyond internships; leadership roles, campus employment, and community engagement carry significant employer value and are often more scalable. Agility must be modeled institutionally. Employers value adaptability, and colleges and universities cannot promote it in students while resisting change themselves. Bonus Takeaway from Dr. McNaughton: Employers continue to value higher education and the four-year degree, despite political rhetoric and cost-driven narratives suggesting otherwise. This disconnect presents both a risk and an opportunity for institutional leaders. This conversation offers data-grounded insight into how employers actually view higher education—and what leaders can do to align strategy, communication, and culture with those expectations. Read the full transcript: https://changinghighered.com/strategic-insights-2025-aacu-employer-survey/ #HigherEducation #HigherEducationLeadership #AACU #EmployerSurvey #WorkforceReadiness #ChangingHigherEdPodcast

Over 5 million people worldwide have been trained in the American College of Surgeons Stop the Bleed program. The program aims to make these life-saving skills as common as CPR. Following the Brown University shooting claiming the lives of two students and leaving nine others injured, we talk about the importance of trauma response skills from hospitals to the everyday bystander. We spoke with Dr. Shea Gregg, Chair of Surgery at SVMC and Chair of CT State Trauma Committee.

(0:00) Intro.(1:27) About the podcast sponsor: The American College of Governance Counsel.(2:14) Start of interview. *Reference to prior episodes/reports with Richard (E126 from Feb 2024 and E158 from Dec 2024)(3:11) AI dominance in public and private markets(4:14) About WSGR's 2025 SV150 Corporate Governance Report. Major Findings in DEI Disclosure (impact on board diversity)(12:25) Broader ESG Changes and Challenges to SEC Climate Disclosure Rule(16:03) California approach to climate risk disclosures (SB 253 and SB 261) and greenhouse gas emissions disclosure(19:04) State vs. Federal Regulatory Landscape(21:13) On SEC's change of policy relating to mandatory arbitration bylaws(23:41) SEC Changes Under Chair Atkins: changes in exec comp disclosures and removing quarterly reporting (27:18) SEC Changes to Rule 14a-8 proposals(29:23) On Lack of Minority Party SEC Commissioners(32:30) Delaware vs. Other States on Corporate Incorporations(39:26) Other findings from the 2025 report. Including on dual-class shares and sunset provisions.(41:12) The State of Private Markets, IPOs and VC(49:55) Biggest winner in business in 2025(50:55) Biggest loser in business in 2025(53:00)  Biggest business surprise in 2025(54:32) Best and worst corporate governance trend from 2025(58:18)  What's the biggest corporate governance trend to watch out for in 2026Richard Blake is a partner at Wilson Sonsini and the leader of the firm's public companies' practice. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Visit ⁠⁠⁠https://longevitybuilders.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠to discover book and The Longevity Builder Health Lab.Episode SummaryFor decades, the standard medical advice for cancer patients was simple: "Rest. Take it easy. Avoid exertion." Today's guest has spent her career proving that advice is not just outdated—it is dangerous.In this episode, Shane Stubbs sits down with Dr. Kathryn Schmitz, the world's leading authority in Exercise Oncology. Dr. Schmitz is the scientist who literally wrote the book on moving through cancer. She spearheaded the "Exercise is Medicine" initiative and has led over $30 million in research funding to prove that exercise changes the biology of cancer.We dive deep into why building a resilient body is your best defense, the specific "Move, Lift, Eat, Sleep, Log" framework, and how resistance training impacts survivorship.PLUS: Stay tuned until the very end for a "Science Spotlight" Bonus Segment. Shane breaks down new research highlighted by Dr. Rhonda Patrick on "Shear Stress"—explaining the physics of how vigorous exercise can mechanically destroy circulating tumor cells and reverse heart aging by 20 years.The Paradigm Shift: Why the old advice to "rest" during cancer treatment is being replaced by a prescription for movement.The Science: Dr. Schmitz's $30M+ research journey and her role in writing the ACSM guidelines for cancer survivors.The Protocol: The "Move, Lift, Eat, Sleep, Log" framework for building a body that can withstand the "Big Four" (Cancer, Heart Disease, Metabolic Dysfunction, Neurodegeneration).Exercise as Medicine: How specific doses of activity can alleviate symptoms, improve chemotherapy tolerance, and boost survival rates.BONUS Segment: The physics of Shear Stress. We discuss Dr. Rhonda Patrick's breakdown of how high-intensity blood flow can kill Circulating Tumor Cells (CTCs) and scrub your arteries.Dr. Kathryn Schmitz is a Distinguished Professor of Public Health Sciences and a Professor of Physical Medicine and Rehabilitation. A trailblazer in the field of Exercise Oncology, she served as the President of the American College of Sports Medicine (ACSM) and founded the Moving Through Cancer initiative.With a PhD in Exercise Physiology, an MPH in Epidemiology, and over 300 peer-reviewed scientific papers, Dr. Schmitz is the foremost voice on the intersection of movement and malignancy. She is the author of the book Moving Through Cancer.Book: Moving Through Cancer by Dr. Kathryn SchmitzInitiative: Moving Through Cancer (ACSM)Research Spotlight: Dr. Rhonda Patrick on Shear Stress & Circulating Tumor CellsReady to put this science into practice? Don't just listen—execute.Join the Longevity Builder Health Lab to access the protocols, community, and tools you need to build a body that lasts.

This episode features C. William Schwab, MD, FACS, FRCS, a retired US Navy Commander from Philadelphia, who is among the growing number of trauma surgeons urging national trauma readiness. During the Edward D. Churchill Lecture at the American College of Surgeons (ACS) Clinical Congress in Chicago, Dr. Schwab said that the US healthcare system's ability to respond to mass casualty events, including warfare-related injuries, is predicated on the preparedness of every surgeon and hospital system.   Talk about the podcast on social media using the hashtag #HouseofSurgery.  

Lee el blogpost completo: https://ecctrainings.com/cuidado-de-quemaduras-en-zonas-remotas-versus-combate-lecciones-cruzadas-entre-las-guias-jts-y-wms Únete al ECCnetwork en Circle: Sé parte de la comunidad que transforma la educación en emergencias. Activa tu membresía gratuita y accede a contenido exclusivo, foros y eventos. 

Vaccines are one of public health's greatest success stories—but what happens when people start saying no? In this episode, Kevin and Dr. Lisa Wolf dig into the rising tide of vaccine refusal, what's fueling it, and how it's already impacting what we see in the emergency department.  If you've ever struggled to explain vaccine science to a skeptical patient, this episode is essential listening. Resources mentioned: ·       American Academy of Pediatrics vaccination recommendations ·       American College of Obstetricians and Gynecologists vaccine guidelines ·       Studies on shingles vaccine and dementia reduction ·       HPV vaccine and cervical cancer elimination in Scotland ·       Vaccination in the emergency department study Follow us on: Facebook: https://www.facebook.com/Art-of-Emergency-Nursing-276898616569046/  YouTube: https://www.youtube.com/channel/UCJTnz4phtCTjojTIDJo2afA?view_as=subscriber  Twitter: @AoenPodcast Instagram: https://www.instagram.com/artofemergencynursing/  To support the show: Leave an honest review on iTunes. Your ratings and reviews greatly contribute to the success of the podcast, and I appreciate each and every one of them. Subscribe on Apple Podcasts, Google Podcasts, or your preferred podcast platform to never miss an episode. Thank you for being a part of our AOEN community!

In this episode, Becky sits down with Patrick McLaughlin, award-winning author of Cheerful Obedience: A Novel, U.S. Army veteran, Ohio Veterans Hall of Fame inductee, and retired fellow of the American College of Trial Lawyers. Patrick shares how his early life, military service, and career in law shaped his perspective as a storyteller. He reveals the inspirations behind his debut novel, how he chose the striking title Cheerful Obedience, and why he believes readers have connected so deeply with the book—earning it multiple national awards. The conversation explores the themes at the heart of his work: moral duty, personal sacrifice, and the complexities of living with integrity. Patrick discusses the real-world issues his book addresses, the impact he hopes to create for readers, and what it means to bring authenticity and emotional truth into fiction.   Whether you're a fan of character-driven fiction, military-inspired stories, or the craft of writing itself, this episode offers a rich and thoughtful conversation with an author whose life experience deeply informs his art. Visit AMPlify Audiobooks to explore Cheerful Obedience and learn more about Patrick McLaughlin's work.

Doctor Mau Informa ®️#drmauinforma 

Host Dr. Joe Patterson sits down with Drs. Michael Sutherland, Bryant Oliphant, and Jennifer Hagen to talk about the American College of Surgeons Committee on Trauma and how orthopedic trauma surgeons can get involved and benefit from the organization in daily practice. Live from the OTA 2025 Annual Meeting. For more information and to become an ACS member, click here. For additional educational resources visit OTA.org  

Welcome to the Legal Nurse Podcast, where complex medical topics meet the world of litigation. In this episode, host Pat Iyer sits down with Dr. Allison Muller, a seasoned toxicologist who brings her expertise to the forefront of the ongoing opioid crisis. Together, they delve into the multifaceted role opioids play in patient care, legal cases, and toxicology, offering invaluable insights for legal nurse consultants and medical professionals alike. Throughout their conversation, Pat Iyer and Allison Muller unpack the intricacies of opioid administration, the significance of accurate medical record documentation, and the challenges of interpreting toxicology reports, especially in postmortem cases. Dr. Muller sheds light on key concepts such as opioid tolerance versus naivety, risks of over-sedation, and the life-saving but often misunderstood role of naloxone in reversing opioid overdoses. Whether you're navigating your first toxicology-related case or looking to deepen your understanding of opioid implications in acute care settings, this episode offers practical guidance and real-world examples. From common pitfalls in toxicology interpretation to the criteria for bringing a toxicologist onto your legal team, Dr. Muller and Pat Iyer provide a roadmap for safer patient care and stronger case outcomes. What you'll learn in this episode on Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Here are five intriguing questions that this podcast answers: How should medical records be reviewed to accurately track opioid administration in acute care settings, and what are the limitations of toxicology blood levels in this context? Why do toxicology reports from autopsies take so long to be completed, and what complexities are involved in determining the substances present in a decedent's system? What is the difference between opioid naive and opioid tolerant patients, and why is understanding these distinctions critical for safe opioid prescribing? What are the best practices for administering Naloxone (Narcan) in cases of opioid overdose, and why is timing so crucial for its effectiveness? When is it appropriate for a legal nurse consultant to recommend involving a toxicologist in a case, especially when interpreting complex toxicology results? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. Grow Your LNC Business 13th LNC SUCCESS® ONLINE CONFERENCE April 23, 24, and 25, 2026 Skills, Strategy, Results Gain deposition mastery, marketing confidence, and clinical–legal insight from industry leaders you can apply to your next case and client call. Build a Practice Attorneys Remember Learn exactly how to showcase expertise, attract referrals, and turn complex medical records into clear, defensible stories that win trust. Learn From the Best—Then Ask Them Anything Get step-by-step training, live “hot seat” solutions, and exclusive VIP Q&A time with Pat Iyer to accelerate your LNC growth. Register now- Limited spots available Your Presenters for Navigating Opioid Cases: Insights from a Toxicologist on Medical Records and Overdose Risks Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Allison Muller Toxicologist with a passion for science, family, and the outdoors. Board-certified clinical toxicologist, fellow of the American Academy of Clinical Toxicology, affiliate fellow of the American College of Medical Toxicology, and faculty at the University of Pennsylvania School of Veterinary Medicine. Scientist with a flair for explaining the hard stuff to the triers of fact and anyone who wants to learn toxicology! When she isn't on this podcast, she's caring for an orange tabby cat and a dwarf bunny (luckily the tabby doesn't know his best friend is a bunny!) Connect with Allison Muller by email at Allison@AcriMullerConsulting.com

Common Form 709 mistakes can trigger costly GST and gift-tax consequences. ACTEC experts explain how to spot and fix DSUE, GST allocation, and gift-splitting errors. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

Monday, December 8th, 2025Today, Brian Cole confessed to planting the pipe bombs the night before the insurrection and is a MAGA election denier; the developer of the ICE Block app is suing officials from DHS ICE DOJ and the White House; the DOJ is considering taking a third swipe at getting a grand jury to indict NYAG Letitia James; the Government Accountability Office is investigating Bill Pulte - the guy who made all the mortgage fraud referrals to DOJ; the Indiana House advances it's 9-0 map to the Senate; the DOJ has already started stonewalling judge Boasberg in his contempt proceedings against against government officials; Rep Adelita Grijalva was pepper sprayed by ICE after identifying herself as a Congresswoman; Kash Patel ordered a tactical SWAT guy to give his girlfriend's drunk pal a ride home; an internal BOP memo halts rape protections for trans inmates; the Department of Health and Human Services deadnamed an official on her portrait; a judge has ordered the unsealing of Epstein grand jury materials; and Allison and Dana deliver and your Good News.Guest: Joshua Aaron of ICEBlock apphttps://www.iceblock.apphttps://bsky.app/profile/joshua.stealingheather.comhttps://www.tixeconsulting.comGuest: Deirdre von DornumProminent federal criminal defense attorney - 23 years at Federal Defenders of New York - Attorney-in-Charge for the Eastern District; Fellow of the American College of Trial Lawyers. Specializing in complex federal cases, indigent defense, civil rights, and pro bono work.https://www.youtube.com/@MSWMediaPodsStoriesDrag queen Pattie Gonia completes 100-mile trek raising $1m to make outdoors more ‘equitable' | California | The GuardianRep. Adelita Grijalva says she was 'sprayed in the face' during ICE confrontation | NBC NewsIndiana House GOP advances 9-0 congressional map, sending contentious plan to state Senate | CBS NewsPipe bomb suspect confesses and has expressed support for Trump, sources say | MS NOWKash Patel ordered FBI detail to give girlfriend's pal a lift home: sources | MS NOWDOJ won't say what it advised Noem amid contempt inquiry over El Salvador deportations | ABC NewsHHS changed the name of transgender health leader on her official portrait | NPR NewsGovernment Accountability Office opens investigation into FHFA chief Bill Pulte | NBC NewsDOJ orders prison inspectors to stop considering LGBTQ safety standards | NPRJudge orders unsealing of grand jury transcripts from Epstein case in Florida | CBS NewsGood Troublehttps://near.tl/sm/ik-ZushRaEllen She/HerRhode Island continues to fight ICE. Ice vehicles are routinely spotted parked near or circling the courthouse. A WhatsApp text goes out to be present and witness/ hopefully prevent ice kidnappings. If you are a RI local, please sign up. If not, your community likely has something similar.Ice Watch RI WhatsApp channel:‎Follow the Alerta de Migra / ICE Watch RI channel on WhatsApp: https://whatsapp.com/channel/0029VbBK6Y229759BqNu3p2mPROTECT YOURSELF AND YOUR COMMUNICATIONS WHEN USING WHATSAPP:https://securityinabox.org/en/tools/whatsappFront Line Defenders:https://www.frontlinedefenders.org/enJoin Dana and The Daily Beans and support on Giving Tuesdayhttp://onecau.se/_ekes71From The Good Newshttps://www.aafront.org/fbklivehttps://www.mprnews.org/story/2025/12/02/escalation-of-rhetoric-from-white-house-targeting-somalis-is-unhinged-says-somali-scholarhttps://www.summitdogrescue.org/meet-fressi--fresita.html→Please submit your own at https://DailyBeansPod.com - click on ‘Good News and Good Trouble'Our Donation Linkshttps://www.nationalsecuritylaw.org/donate, https://secure.actblue.com/donate/msw-bwc, http://WhistleblowerAid.org/beansFederal workers - email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Dr. Allison Gill - https://muellershewrote.substack.com, https://bsky.app/profile/muellershewrote.com, https://instagram.com/muellershewrote, https://twitter.com/MuellerSheWrote, https://www.youtube.com/@MSWMediaPodsDana Goldberg - https://bsky.app/profile/dgcomedy.bsky.social, https://twitter.com/DGComedy, https://www.instagram.com/dgcomedy, https://www.facebook.com/dgcomedy, https://danagoldberg.comMore from MSW Media - https://mswmedia.com/shows, Cleanup On Aisle 45 pod, https://muellershewrote.substack.comReminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Our Donation LinksNational Security Counselors - DonateMSW Media, Blue Wave California Victory Fund | ActBlueWhistleblowerAid.org/beansFederal workers - feel free to email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Find Upcoming Actions 50501 Movement, No Kings.org, Indivisible.orgDr. Allison Gill - Substack, BlueSky , TikTok, IG, TwitterDana Goldberg - BlueSky, Twitter, IG, facebook, danagoldberg.comCheck out more from MSW Media - Shows - MSW Media, Cleanup On Aisle 45 pod, The Breakdown | SubstackShare your Good News or Good TroubleMSW Good News and Good TroubleHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?The Daily Beans | SupercastThe Daily Beans & Mueller, She Wrote | PatreonThe Daily Beans | Apple Podcasts Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Contributor: Aaron Lessen, MD Educational Pearls: How do amiodarone and lidocaine work on the heart? Amiodarone Blocks potassium channels (Class III effect). Also blocks sodium and calcium channels. Additional noncompetitive beta-blocker effects. Stabilizes cardiac tissue, slows heart rate, and suppresses both atrial and ventricular arrhythmias. Lidocaine Blocks fast sodium channels in ventricular tissue (Class Ib). Shortens the action potential in ventricular myocardium, especially in ischemic tissue. Suppresses abnormal automaticity in damaged/irritable myocardium. Which one should you pick for a patient in vtach/vfib cardiac arrest? The current guidelines recommend amiodarone for shock-refractory cases but this is based on randomized trials showing better arrhythmia termination and short-term outcomes, but not long-term survival benefits. Two recent studies suggest that lidocaine might actually be preferable. A 2023 paper published in Chest Performed a large retrospective cohort study for treating in-hospital VT/VF cardiac arrest. Among more than 14,000 patients, lidocaine was associated with higher rates of ROSC, 24-hour survival, survival to discharge, and favorable neurologic outcomes. These results held after adjusting for covariates and using propensity score methods. Overall, lidocaine outperformed amiodarone across all major clinical outcomes in this population. A 2025 paper published in Resuscitation Performed a target trial emulation in adults with out-of-hospital shockable cardiac arrest. After propensity score matching in more than 23,000 eligible cases, lidocaine was associated with higher odds of prehospital ROSC, fewer post-drug defibrillations, and greater survival to hospital discharge. These advantages were consistent across matched patient pairs. Dose for lidocaine is an initial 1-1.5 mg/kg IV bolus, followed by additional boluses of 0.5-0.75 mg/kg every 5-10 minutes up to a total of 3 mg/kg if needed. Dose for amiodarone is a 300 mg bolus followed by an additional 150 mg bolus if needed. References Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30. Erratum in: Heart Rhythm. 2018 Nov;15(11):e278-e281. doi: 10.1016/j.hrthm.2018.09.026. PMID: 29097320. Smida T, Crowe R, Price BS, Scheidler J, Martin PS, Shukis M, Bardes J. A retrospective 'target trial emulation' comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation. Resuscitation. 2025 Mar;208:110515. doi: 10.1016/j.resuscitation.2025.110515. Epub 2025 Jan 23. PMID: 39863130; PMCID: PMC11908894. Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RW. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Chest. 2023 May;163(5):1109-1119. doi: 10.1016/j.chest.2022.10.024. Epub 2022 Nov 2. PMID: 36332663. Summarized by Jeffrey Olson, MS4 | Edited by Jeffrey Olson and Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462 Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You'll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients' quality of life. Episode resource links: El Hussein, M. T., & Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501. Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... & Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578. Charles, A. C., Tepper, S. J., & Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain. Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025 Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... & Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

For this episode hosts Drew, Tanner, and Andy are joined by performance scientist Jason Brooks to discuss the topic of Mental Interference. Do't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org to learn more about this organization and how you can attend a future CME event!

(0:00) Intro(1:21) About the podcast sponsor: The American College of Governance Counsel(2:08) Start of interview(2:36) Michelle's origin story(4:33) The Origins of Footnoted (started in 2003)(6:36) Understanding SEC Filings and Disclosures(7:20) The "Friday Night Dump"(9:34) The State of Public vs. Private Markets(12:40) The Rise of Private Markets and Challenges of Public Markets(18:43) Red Flags in SEC Filings(22:03) The Evolution of Executive Compensation and Elon Musk's Comp(28:53) Egregious Corporate Governance examples: Sketchers.(30:08) The problem of Related Party Transactions.(31:37) Independence and Compensation of Board Members (32:36) Quote of Charlie Munger and Warren Buffett on this topic(36:33) Are we in a AI bubble? Similarities with Enron/Worldcom era? (40:18) Reference to my article on AI washing(41:43) The Importance of SEC Changes (only 3 commissioners from a single party)(43:22) The Role of Markets in Everyday Life(47:45) Books that have greatly influenced her life:The Jungle by Upton Sinclair (1906)Germinal by Émile Zola (1885)Crying in H Mart by Michelle Zauner (2021)(48:20) Her mentors: Nell Minow, Diana Henriques, and Thornton O'Glove.(49:19) Quotes that she thinks of often or lives her life by: "Don't Postpone Joy"(50:52) An unusual habit or an absurd thing that she loves. Michelle Leder is the founder and editor-in-chief of footnoted.com, a source for uncovering important information hidden deep in SEC filings.  You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-462 Overview: In this episode, we examine migraine—a leading cause of disability worldwide that is often underdiagnosed and undertreated in primary care. You'll learn how to distinguish migraine from other headache disorders, identify who is most affected, and explore both acute pharmacologic options and preventive strategies that can reduce attack frequency and improve patients' quality of life. Episode resource links: El Hussein, M. T., & Fraser, L. (2025). Pharmacologic Management of Migraine in Primary Care: Nurse Practitioner Guide. The Journal for Nurse Practitioners, 21(9), 105501. Qaseem, A., Tice, J. A., Etxeandia-Ikobaltzeta, I., Wilt, T. J., Harrod, C. S., Cooney, T. G., ... & Yost, J. (2025). Pharmacologic treatments of acute episodic migraine headache in outpatient settings: a clinical guideline from the American College of Physicians. Annals of internal medicine, 178(4), 571-578. Charles, A. C., Tepper, S. J., & Ailani, J. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache: The Journal of Head and Face Pain. Vélez-Jiménez MK, et al. Comprehensive Preventive Treatments for Episodic Migraine: Systematic Review. Front Neurol. 2025 Lanteri-Minet, M., Casarotto, C., Bretin, O., Collin, C., Gugenheim, M., Raclot, V., ... & Lefebvre, H. (2025). Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. The Journal of Headache and Pain, 26(1), 153. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Peter Robbins returns to the show, and we talk about his return to the UK and Rendlesham, and then get into the life and research of Wilhelm Reich. If you are not familiar with the man, you should be. You will see why on this show. Peter is of course best known for his work on the Rendlesham Forest case, but has an extensive resume dealing with Reich as well. Peter Robbins was first introduced to the books of Wilhelm Reich as a teenager by a college roommate, to whom he remains deeply indebted. In 1976 he met Dr. Elsworth F. Baker, Reich's first assistant for the last eleven years of his life. Soon after this he became a patient of Dr. Baker and entered into almost seven years of medical orgone therapy with the distinguished orgonomist.Robbins went on to enroll in the classes New York University offered in scientific and social orgonomy which was taught by the Reich scholars Professors John Bell and Paul Matthews. They in turn invited him to become a member of their ongoing Seminar in Social and Scientific Orgonomy, patterned after the seminars which Sigmund Freud presided over during the nineteen twenties. Peter spent much of the nineteen eighties involved with this group, presenting a variety of papers to his fellow seminar members under Matthews' and Bell's guidance and leadership.Peter was a volunteer fundraiser for the American College of Orgonomy's (ACO) Building Fund and had two papers on Wilhelm Reich and UFOs published in the Journal of Orgonomy. He was part of a select group of volunteers invited to witness a demonstration of cloudbusting technology and presented on the subject of Reich and UFOs at the ACO's Princeton NJ facility, and at international conferences on the life and work of Reich in New York City, Ashland Oregon, Niece France and Karavomilos Greece. His lectures have been well received at numerous scientific and UFO conferences both here and abroad while his articles on the subject have been published in a variety of print and web publications. Robbins' extensively researched paper, “Politics, Religion and Human Nature: Practical Problems and Roadblocks on the Path Toward Official UFO Acknowledgment” is scheduled to be published in the upcoming issue of Annals of the Institute for Orgonomic Science. Hosted on Acast. See acast.com/privacy for more information.

In this episode, the CardioNerds (Dr. Naima Maqsood, Dr. Akiva Rosenzveig, and Dr. Colin Blumenthal) are joined by renowned educator in electrophysiology, Dr. Joshua Cooper, to discuss everything atrial flutter; from anatomy and pathophysiology to diagnosis and management. Dr. Cooper's expert teaching comes through as Dr. Cooper vividly describes atrial anatomy to provide the foundational understanding to be able to understand why management of atrial flutter is unique from atrial fibrillation despite their every intertwined relationship. A foundational episode for learners to understand atrial flutter as well as numerous concepts in electrophysiology. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls "The biggest mistake is failure to diagnose”. Atrial flutter, especially with 2:1 conduction, is commonly missed in both inpatient and outpatient settings so look carefully at that 12-lead EKG so you can mitigate the stroke and tachycardia induced cardiomyopathy risk  Decremental conduction of the AV node makes it more challenging to rate control atrial flutter than atrial fibrillation  Catheter Ablation is the first line treatment for atrial flutter and is highly successful, but cardioversion can be utilized as well prior to pursuing ablation in some cases.  Class I AADs like propafenone and flecainide may stability the atrial flutter circuit by slowing conduction and thus may worsen the arrhythmia. Therefore, the preferred anti-arrhythmic medication in atrial flutter are class III agents.  Atrial flutter can be triggered by firing from the left side of the heart, so in patients with both atrial fibrillation and flutter, ablating atrial fibrillation makes atrial flutter less likely to recur.  BONUS PEARL: Dr. Cooper's youtube video on atrial flutter is a MUST SEE!  Notes Notes: Notes drafted by Dr. Akiva Rosenzveig  What are the distinguishing features of atrial fibrillation and flutter?  Atrial flutter is an organized rhythm characterized by a wavefront that continuously travels around the same circuit leading to reproducible P-waves on surface EKG as well as a very mathematical and predictable relationship between atrial and ventricular activity  Atrial fibrillation is an ever changing, chaotic rhythm that consists of small local circuits that interplay off each other. Consequently, no two beats are the same and the relationship between the atrial activity and ventricular activity is unpredictable leading to an irregularly irregular rhythm  What are common atrial flutter circuits?  Cavo-tricuspid isthmus (CTI)-dependent atrial flutter is the most common type of flutter. It is characterized by a circuit that circumnavigates the tricuspid valve.  Typical atrial flutter is characterized by the circuit running in a counterclockwise pattern up the septum, from medial to lateral across the right atrial roof, down the lateral wall, and back towards the septum across the floor of the right atrium between the IVC and the inferior margin of the tricuspid valve i.e. the cavo-tricuspid isthmus. Surface EKG will show a gradual downslope in leads II, III, and AvF and a rapid rise at end of each flutter wave.   Atypical CTI-dependent flutter follows the same route but in the opposite direction (clockwise). Therefore, we will see positive flutter waves in the inferior leads   Mitral annular flutter is more commonly seen in atrial fibrillation patients who've been treated with ablation leading to scarring in the left atrium.  Roof-dependent flutter is characterized by a circuit that travels around left atrium circumnavigating a lesion (often from prior ablation), traveling through the left atrial roof, down the posterior wall, and around the pulmonary veins  Surgical/scar/incisional flutter is seen in people with a history of prior cardiac surgery and have iatrogenic scars in right atrium due to cannulation sites or incisions  How does atrial flutter pharmacologic management differ from other atrial arrhythmias?  The atrioventricular (AV) node is unique in that the faster it is stimulated, the longer the refractory period and the slower it conducts. This characteristic is called decremental conduction. In atrial fibrillation, the atrial rate is so fast that the AV node becomes overwhelmed and only lets some of those signals through to the ventricles creating an irregular tachycardia but at lower rates. In atrial flutter, the atrial rate is slower, therefore the AV node has more capability to conduct allowing for higher ventricular rates. Therefore, to achieve rate control one will need a higher dose of AV blocking medications. Atrial tachycardia may require even higher doses due to the increased ability of the AV node to conduct, as the atrial rates are slower than in atrial flutter.  Sodium channel blockers (Class I) such as flecainide and propafenone slow wavefront propagation, making it easier for the AV node to handle the atrial rates. This will end up leading to increased ventricular rates which can be dangerously fast. That is why AV nodal blockers should be used in conjunction with flecainide and propafenone.  What is the role of cardioversion in atrial flutter management?  Due to high success rate with atrial flutter ablation, ablation is the first line treatment. However, sometimes cardioversion may be utilized in patients depending on how symptomatic they are and how long it will take to get an ablation. Cardioversion may also be utilized preferentially when the atrial flutter was triggered by infection or cardiac surgery to see if it will come back.   If cardioversion is pursued, the patient will need to be anticoagulated due to the stroke risk after the procedure due to post-conversion stunning.  How effective is atrial flutter ablation?  The landmark Natale et al study in 2000 demonstrated 80% success rate after radiofrequency ablation as compared to 36% in patients on anti-arrhythmic therapy. The LADIP study in 2006 further corroborated these findings. Contemporary data shows above 90% success rate of atrial flutter ablation.  In patients who have had both atrial fibrillation and atrial flutter, most electrophysiologists would ablate both. However, in patients with atrial fibrillation, the atrial flutter usually is initiated by trigger spots firing in the left atrium. Once the atrial fibrillation is ablated, the flutter will become less likely. Therefore, there are those who say there's no need to ablate the flutter circuit as well. Alternatively, if a patient has severe comorbidities and/or is high risk for ablation, one may consider performing the atrial flutter ablation only since atrial flutter is harder to manage medically compared with atrial fibrillation.   How do you manage atrial flutter in the acute inpatient setting?  In the inpatient setting, electrical cardioversion is often limited by blood pressure and the hypotensive effects of the sedatives required. If one is awake and too hypotensive, chemical cardioversion can be pursued. The most effective anti-arrhythmic for this is ibutilide. Amiodarone is not effective for acute cardioversion. Since ibutilide prolongs refractoriness in atrial and ventricular tissue, there's a risk of long QT induced torsades de pointes. Pretreating with magneisum reduces the risk to 1-2%.  References Jolly WA, Ritchie WT. Auricular flutter and fibrillation. 1911. Ann Noninvasive Electrocardiol. 2003;8(1):92-96. doi:10.1046/j.1542-474x.2003.08114.x  McMichael J. History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. Br Heart J. 1982;48(3):193-197. doi:10.1136/hrt.48.3.193  Lee KW, Yang Y, Scheinman MM; University of Califoirnia-San Francisco, San Francisco, CA, USA. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol. 2005;30(3):121-167. doi:10.1016/j.cpcardiol.200  2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e167. doi:10.1161/  Cosío F. G. (2017). Atrial Flutter, Typical and Atypical: A Review. Arrhythmia & electrophysiology review, 6(2), 55–62. https://doi.org/10.15420/aer.2017.5.2  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-11/Atrial-flutter-common-and-main-atypical-forms Natale A, Newby KH, Pisanó E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898-1904. doi:10.1016/s0735-1097(00)00635-5  Da Costa A, Thévenin J, Roche F, et al. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114(16):1676-1681. doi:10.1161/CIRCULATIONAHA.106.638395  https://www.acc.org/Membership/Sections-and-Councils/Fellows-in-Training-Section/Section-Updates/2015/12/15/16/58/Atrial-Fibrillation#:~:text=The%20first%20'modern%20day'%20account,in%20open%20chest%20animal%20models.&text=In%201775%2C%20William%20Withering%20first,(purple%20foxglove)%20in%20AFib.

Last week Cyprus and Lebanon signed a long-awaited maritime demarcation deal, an agreement that not only paves the way for potential exploration and energy cooperation, but also checks Turkey's revisionist “Blue Homeland” doctrine in the Eastern Mediterranean. Constantinos Filis, the director of the Institute of Global Affairs and a professor of international relations at the American College of Greece, joins Thanos Davelis as we look into what's being called a “historic” deal that also serves to bridge the EU with the Middle East.You can read the articles we discuss on our podcast here:Cyprus–Lebanon deal sets new legal line in the Eastern Med, and Ankara isn't loving itLebanon, Cyprus sign maritime deal, paving way for possible energy explorationGreece, Bulgaria and Romania sign agreement on Aegean-Black Sea corridorCyprus pledges Ukraine will be ''front and center” during EU presidency

In this episode, Guy talked with Dr. Nisha Manek. She challenges conventional understandings of consciousness and delves into the intersection of science and spirituality. Emphasizing that consciousness is not a product of the brain, Nisha discussed the latent capacities of human beings and the need to elevate our levels of conscious awareness. Through her experiences as a medical doctor and her studies with physicist William Tiller, she explored the potential of intention to affect physical reality, the limitations of modern medicine, and the importance of inner work. Nisha also shared practical advice on meditation and the transformative power of silence. About Dr. Nisha: Nisha Manek is an internally recognized leader in the field of integrative medicine. Nisha's humble background from Kenya propelled her to transcend limitations: gender, ethnicity, and financial status. From Case Western Reserve University in Cleveland, Ohio, where she graduated Summa cum laude, to the University of Glasgow School of Medicine in Scotland, Nisha's uncommon tenacity has driven her to ask difficult questions and pursue answers beyond traditional medical paradigms.  Nisha began her career in rheumatology at the Mayo Clinic in Rochester, Minnesota. Recognized as Teacher of the Year in the School of Medicine, she brings storytelling as a core skill to bedside medical teaching and on the plenary stage.  But she didn't stop there. Nisha partnered with one of the world's most innovative physicists, Emeritus Professor William A. Tiller of Stanford University, and pushed the boundaries of what is possible in medicine. She is the preeminent doctor of information medicine, which intersects consciousness, biofield science, and rheumatology to improve human health.  She has authored a one-of-a-kind book, Bridging Science and Spirit, which closes the gap between two seemingly separate areas of knowledge. She is a fellow of the American College of Physicians and a fellow of the Royal College of Physicians of the United Kingdom. Key Points Discussed:  (00:00) - The Hidden Science of Consciousness They Never Taught Us! (00:41) - Welcome to the Podcast (01:11) - The Seeker of Truth (01:43) - Straying from the Truth (02:57) - The Invisible Essence of Consciousness (04:46) - Bridging Science and Spirit (07:25) - The Role of Intention in Medicine (08:07) - The Human Behind the Technology (09:42) - The Power of Consciousness and Intention (12:59) - Meeting William Tiller (22:59) - The Experiment with Water (26:40) - The Unique Feel of Different Spaces (27:13) - The Sacredness of Tiller's Lab (27:49) - Bridging Science and Spirit (29:11) - The Power of Intention and Energy (32:11) - The Potential of Human Consciousness (39:51) - Daily Practices for Consciousness (49:05) - Reflections and Personal Journey (51:09) - Final Thoughts and Book Information How to Contact Dr. Nisha Manek:www.nishamanekmd.com   About me:My Instagram: www.instagram.com/guyhlawrence/?hl=en Guy's websites:www.guylawrence.com.au www.liveinflow.co''

Advisors everywhere are feeling the pressure to scale, hire, and prepare for a wave of retirements that will reshape the industry. At the same time, firms are struggling to attract women, keep next-gen advisors engaged, and build teams that actually create freedom instead of more work.That's why I wanted to bring Lindsey Lewis on the show. After building a $200M book in her first year at Vanguard, Lindsey shifted her career toward research at The American College so she could help the profession fix its biggest blind spots—especially around women in finance, advisor retention, and the future talent pipeline.We dig into the data shaping the next decade of financial services: what women uniquely bring to advisory firms, why Gen Z is more interested in this profession than any generation before them, and how training, compensation, and career clarity determine whether young advisors stay or disappear.4 of the biggest insights from Lindsey …#1.) The Biggest Talent Gap in Advisor HistoryWe're staring down a generational shift in this profession. Tens of thousands of advisors are aging out. And when you run the math, the industry would need to hire over a million new people just to meet today's demand. Lindsey walks through the data behind this massive workforce gap and why the firms who build real training, career paths, and development now will be miles ahead of everyone else over the next decade.#2.) Women Advisors Are a Huge Missed OpportunityThe numbers don't lie: women make up 25% of CFPs… but only a small fraction are in sales/growth positions. And it's not a talent issue, it's how the industry has shaped roles, pay structures, and expectations over time. Lindsey breaks down why women often outperform in retention, personalization, referrals, and relationship depth, yet get pushed into service tracks or stay risk-averse because of cultural narratives, confidence gaps, or biases inside firms. The upside for the firms who fix this is enormous. Women represent one of the biggest untapped growth engines in financial services.#3.) Gen Z Wants In, But Poor Onboarding Pushes Them OutHere's the part no one expects: financial services is now Gen Z's top-preferred industry over tech and medicine. But at the same time, 1 in 4 early-career advisors say their onboarding wasn't effective — and those are the same people who leave within seven years. Lindsey lays out exactly what this generation needs to stay: mentorship, sponsorship, clear career paths, ongoing education, and roles that evolve with their confidence. If you want a talent pipeline that sticks, it starts with the first 12–18 months.#4.) Compensation Makes or Breaks Your TeamComp plans aren't just about money, they're about psychology. Young advisors need stability before they're ready to take on variable comp. Others crave upside and hate the idea of a flat salary. Lindsey explains the difference between income risk tolerance and income risk capacity, and why misalignment between the person and the pay structure is one of the biggest drivers of turnover. When firms get comp wrong, they churn through talent. When they get it right, people stay, grow, and eventually step into the very roles the industry is desperate to fill. SHOW NOTEShttps://bradleyjohnson.com/145FOLLOW BRAD JOHNSON ON SOCIALTwitterInstagramLinkedInFOLLOW DBDL ON SOCIAL:YouTubeTwitterInstagramLinkedInFacebookDISCLOSURE DBDL podcast episode conversations are intended to provide financial advisors with ideas, strategies, concepts and tools that could be incorporated into their business and their life. No statements made in the episode are offered as, and shall not constitute financial, investment, tax or legal advice. Financial professionals are responsible for ensuring implementation of anything discussed related to business is done so in accordance with any and all regulatory, compliance responsibilities and obligations. The Triad member statements reflect their own experience which may not be representative of all Triad Member experiences, and their appearances were not paid for. Triad Wealth Partners, LLC is an SEC Registered Investment Adviser. Please visit Triadwealthpartners.com for more information. Triad Wealth Partners, LLC and Triad Partners, LLC are affiliated companies. TP11254981366See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Discover how artificial intelligence is revolutionizing heart disease prevention and treatment with Dr. Ami Bhatt, Chief Innovation Officer at the American College of Cardiology.From AI-powered early detection tools to personalized risk prediction, learn how new technologies are making quality cardiac care more accessible while preserving the essential human element of medicine. Dr. Bhatt shares fascinating insights about the innovations transforming cardiovascular health today and her vision for even more remarkable advances coming in the next five years.You can find Ami at: Website | LinkedIn | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.